Pharmaceutical company Astellas' settlement with the U.S. Department of Justice for more than $102 million over its alleged Medicare fraud scheme involving medication for castration-resistant prostate cancer may be covered by...
To view the full article, register now.
Read Full Story: https://news.google.com/__i/rss/rd/articles/CBMidWh0dHBzOi8vd3d3LmxhdzM2MC5jb...
Welcome to Reality Check, NewsGuard’s nonpartisan newsletter that tracks the false claims and conspiracy theories that shape our world — and who’s behind them. Please support us by becoming a premi...